Search

Search

このページは機械翻訳されています。他のページは英語で表示される場合があります。 View in English

ホーム
...
研究分野生物医学と臨床科学腫瘍学とがん発生分子標的
編集者訂正:切除不可能なデスマプラスティックメラノーマにおける抗PD-1療法:第2相SWOG S1512試験

編集者訂正:切除不可能なデスマプラスティックメラノーマにおける抗PD-1療法:第2相SWOG S1512試験

Kari L Kendra ¹, Shay L Bellasea ^2,3, Zeynep Eroglu ⁴, Siwen Hu-Lieskovan ⁵, Katie M Campbell ⁶, William E Carson ⁷, David A Wada ⁵, Jose A Plaza ⁷, Jeffrey A Sosman ⁸, Gino K In ⁹, Alexandra Ikeguchi ^10,11, John Hyngstrom ^5,12, Andrew S Brohl ⁴, Nikhil I Khushalani ⁴, Joseph Markowitz ⁴, George Negrea ¹³, Samer Kasbari ¹⁴, Gary C Doolittle ¹⁵, Umang Swami ⁵, Toni Roberts ¹⁶, Boban N Mathew ¹⁷, Egmidio Medina ⁶, Ignacio Baselga-Carretero ⁶, Cynthia R Gonzalez ⁶, Ivan Perez Garcilazo ⁶, Agustin Vega-Crespo ⁶, Jia Ming Chen ⁶, Nataly Naser Al-Deen ⁶, Sapna P Patel ¹¹, Elad Sharon ^18,19, James Moon ^2,3, Michael C Wu ^2,3, Antoni Ribas ²⁰

Kari L Kendra ¹, Shay L Bellasea ^2,3, Zeynep Eroglu ⁴

¹Ohio State University Wexner Medical Center, Columbus, OH, USA. kari.kendra@osumc.edu.
²SWOG Statistics and Data Management Center, Seattle, WA, USA.
³Fred Hutchinson Cancer Center, Seattle, WA, USA.
⁴H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
⁵Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
⁶Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA.
⁷Ohio State University Wexner Medical Center, Columbus, OH, USA.
⁸Northwestern University, Chicago, IL, USA.
⁹Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
¹⁰University of Oklahoma Stephenson Cancer Center, Oklahoma City, OK, USA.
¹¹The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
¹²RUSH MD Anderson Cancer Center, Chicago, IL, USA.
¹³Lewis Cancer and Research Pavilion, Savannah, GA, USA.
¹⁴Southeastern Medical Oncology Center, Goldsboro, NC, USA.
¹⁵University of Kansas Cancer Center, Westwood, KS, USA.
¹⁶Saint Michael Cancer Center, Bremerton, WA, USA.
¹⁷Masonic Cancer Alliance, Freeman Cancer Center, Pittsburgh, PA, USA.
¹⁸Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
¹⁹Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
²⁰Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA. aribas@mednet.ucla.edu.

⁰Ohio State University Wexner Medical Center, Columbus, OH, USA. kari.kendra@osumc.edu.

Nature Medicine +

|

2025年8月26日

関連する実験動画

These videos have been matched automatically. Contact us if they are not relevant.

A Melanoma Patient-Derived Xenograft Model

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

Patient-Derived Tumor Explants As a

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

See all related videos

まとめ

No abstract available on PubMed

関連する実験動画

自動的に一致したビデオです Contact us もしそれらが関連していない場合

A Melanoma Patient-Derived Xenograft Model

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

See all related videos

関連する概念動画

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Share

X
Facebook
LinkedIn
YouTube

ABOUT JoVE

Overview
Leadership
Blog
JoVE Help Center

AUTHORS

Publishing Process
Editorial Board
Scope & Policies
Peer Review
FAQ
Submit

LIBRARIANS

Testimonials
Subscriptions
Access
Resources
Library Advisory Board
FAQ

RESEARCH

JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive

EDUCATION

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Faculty Site

Terms & Conditions of Use
Privacy Policy
Policies